Featured Link
What Doctors Say

Gary J. Schiller, M.D.

Director of Leukemia Studies and Leukemia Clinic,
University of California School of Medicine, Los Angeles.
Member of Cryobank's Medical Board of Advisors.

"Cord blood offers a potential hope for patients with life-threatening malignancies awaiting transplantation. In the future, this important resource may make transplant feasible to a large number of patients who now have no donors from their families or through the registries. I believe in the process; that's why we turned over our baby's umbilical cord stem cells to the public through Cryobanks International."

Tom Garite, M.D.

Chairman of the Department of Obstetrics and Gynecology &
Director of the Fellowship Program in Maternal Fetal Medicine,
University of California, Irvine.

"Private cord blood banking may be critically important when a family history is indicative of an increased likelihood for use (i.e. malignancy, hemoglobinopathy, inborn errors of metabolism, immune disorders). The overall likelihood for utilizing the private storage is probably 1 in 400, but would be higher when taking into account family use (i.e. potential use by siblings). The potential for cord blood use in regenerative medicine is particularly exciting in the research arena, and may (potentially) increase the likelihood for autologous use significantly in the future."

Sanford Lederman, M.D.

Director of Maternal Fetal Medicine,
Long Island College Hospital.
Member of Cryobank's Medical Board of Advisors.

"Medicine in the 21st century is forever evolving and cord blood stem cells are a critical component today and even more as we look into the future."

Sanford M. Lederman, M.D., F.A.C.O.G.

Eliezer A. Rachmilewitz, M.D.

Eliezer Rachmilewitz, M.D.

Director of the Department of Hematology,
The Edith Wolfson Medical Center in Holon, Israel.
Member of Cryobank's Medical Board of Advisors.

"An exciting development is the option to direct cord blood stem cells to differentiate to several cell lines of specific organs, such as heart and brain. These cells can be added to impaired heart and brain tissues and thus open a whole new venue of treatment, using cord blood cells."


Geralyn M. Meny, M.D.

Medical Director,
American Red Cross, Penn-Jersey region.
Member of Cryobank's Medical Board of Advisors.

"All cord blood banks are not alike. Look for evidence of the company's commitment to a quality program in deciding where to store your baby's cord blood or in selecting the cord blood unit for transplant or research."

Geralyn M. Meny, M.D.